SONATA Dose Duration LIFU for OCD
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 20 people, planned
- Started
- 15 Sept 2026
- Expected to end
- 15 Sept 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- ATTN201 - Low Intensity Focused Ultrasound
- Record updated
- 21 October 2026
Who can take part
- Age
- 22 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 22-80
- Meet DSM-V criteria for OCD ≥ 1 year with a Y-BOCS score ≥ 16
- Must be on the same stable dose(s) of OCD medication for at least 4 weeks prior to screening and throughout the course of the study
Who cannot take part
- Co-morbid psychiatric disorder other than depression or anxiety disorder
- History of neurological condition
- Active suicidal risk (defined by C-SSRS)
- Pregnant or breastfeeding, or planning to become pregnant during the study period
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 22 and 80 years old?
This trial is currently available in United States.
- University of PennsylvaniaPhiladelphia, United StatesContact: Rishi SureshTaking people
About the trial
What the trial wants to find out
This study is testing a new, non-invasive brain stimulation approach for adults with Obsessive Compulsive Disorder (OCD). Researchers are evaluating the safety, tolerability, and target engagement of low-intensity focused ultrasound (LIFU) directed at a brain region called the subthalamic nucleus (STN). The ultrasound is delivered using a wearable device called ATTN201 (developed by Attune Neurosciences).
The 2 groups in the trial
- Active StimulationTreatment being tested
Participants receive low intensity focused ultrasound stimulation
Treatment: ATTN201 - Low Intensity Focused Ultrasound
- Sham StimulationSham treatment, for comparison
Participants received unfocused ultrasound, which mimic the auditory and peripheral sensations of active stimulation without delivering meaningful pressure to the brain target
Treatment: ATTN201 - Low Intensity Focused Ultrasound
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Subcortical OCD Neuromodulation With Acoustic Therapy - Dose Duration Optimization
- Criteria questions
- Built from NCT07887633, who can take part
- Record updated
- 21 October 2026